4//SEC Filing
LEA LEIV 4
Accession 0000899243-18-031810
CIK 0001626971other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:08 PM ET
Size
6.5 KB
Accession
0000899243-18-031810
Insider Transaction Report
Form 4
LEA LEIV
Chief Financial Officer
Transactions
- Purchase
Common Stock, $0.0001 par value
2018-12-21$4.15/sh+24,700$102,409→ 24,700 total(indirect: By IRA)
Holdings
- 149,206(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $4.13 to $4.17 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held by Leiv Lea IRA Contributory.
- [F3]A portion of these shares is subject to a right of repurchase held by the Issuer.
- [F4]These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0000939012
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 4:08 PM ET
- Size
- 6.5 KB